Skip to main content
ConductScienceScienceDex

John K Mich

NIH Rank #3531
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8624334Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2025 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$1.9M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#3,531
By linked amount among FY2026 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for John K Mich. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing John K Mich as a PI. Multi-PI records show the full award amount for context.

  • 1R44NS145930-01A1R44
    Cell class-specific AAV gene therapy for SLC6A1-related neurodevelopmental disorder
    Epicure Therapeutics, Inc.
    $1.5M
    award amount
  • 5R61NS138832-02R61
    Development of an oligonucleotide therapeutic for Dravet syndrome
    Allen Institute
    $393.2K
    award amount

Award organizations

Organizations that administered FY2026 awards listing John K Mich as a PI.

Epicure Therapeutics, Inc.
WA
$1.5M
1 grant
Allen Institute
WA
$393.2K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2025
    First NIH Award
    Epicure Therapeutics, Inc.
  2. 2026
    $500K Cumulative Funding
  3. 2026
    $1M Cumulative Funding
  4. 2026
    $2M Cumulative Funding
  5. 2026
    Entered Top 50% Nationally
    Ranked #3531
  6. 2026
    Entered Top 25% Nationally
    Ranked #3531
  7. 2026
    Multi-Institutional Research
    Awards at 2 institutions

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as John K Mich.

Boaz Pirie Levi
Allen Institute
2
shared awards
Bryan Bentley Gore
Allen Institute
2
shared awards
Boaz Pirie Levi
Epicure Therapeutics, Inc.
1
shared award
Bryan Bentley Gore
Epicure Therapeutics, Inc.
1
shared award
Rong Guo
Epicure Therapeutics, Inc.
1
shared award

Explore further

Find collaborators for John K Mich

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →